We are on TV
The TV show Conexión Asturias (RTPA) showcased Microviable Therapeutics activity in the microbiota field, currently focus on live biotherapeutic products (LBPs) development for Crohn´s disease and Autism Spectrum Disorder. […]
Gut microbiota analysis for prevent COVID-19. Microviable Therapeutics
Gut microbiota analysis may help prevent the more serious effects of COVID-19. With this premise, Microviable seeks funding to design a predictive model and open the possibility of designing treatments from Spain. […]
Towards controlling the “second brain” that inhabits your intestines
View more at “La Voz de Asturias” Microviable Therapeutics offers the possibility of performing a microbiota transplant more comfortably and even storing the microbiota for future therapeutic uses. […]
Microviable Therapeutics pioneer in the field of microbiota.
El Comercio (Diario de Asturias), highlights Microviable’s activity in “the long-term isolation and storage of the microbiota under viable conditions, the analysis of its composition and, finally, the development of microbiome-based therapies. The first two business [...]
Microviable at RTVE
Microviable Therapeutics and its high scientific level deserve the attention of Spanish TV. #microbiota #storage for #therapy #personalized with your own microorganisms. […]
Microviable Therapeutics pioneers the microbiota storage
During the last week, the media had covered the exclusive service of intestinal microbiota storage that we offer. […]